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Abstract. Sparked by the need to inform the response to the spread of
HIV/AIDS in drug injecting populations in the 1980s and the desire to
base local, national and international responses to tackling drug use in
the 1990s on solid epidemiological data, the mark-recapture method has
increasingly been used to estimate the prevalence of drug use. Richard
Cormack provided support and advice to some of the first United King-
dom and European studies to estimate drug use prevalence in this way.
The approach he outlined, using macros that he developed, has led to
the mark-recapture method being used to systematically assess the use
of drugs such as heroin or other opioids in the United Kingdom and
across Europe. We review the development of the method when applied
to estimating the size of drug-using populations, including the use of
Bayesian methods. We discuss its limitations and various criticisms
that have been voiced.
MSC 2010 subject classifications: Primary 62P25 applications to so-
cial sciences, 62-07 data analysis; secondary 62J12 generalized linear
models.
Key words and phrases: Bayesian methods, drugs, heroin use, mark-
recapture, prevalence.
1. INTRODUCTION
1.1 Background
In this paper we describe how the mark-recapture method has been used to
estimate the prevalence of problem drug use. We begin by examining what is
meant by “problem drug use” and go on to provide a brief review of the literature
on mark-recapture estimation of problem drug use, noting a “standard approach”
that was used in many early studies, including a series of studies within the United
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Kingdom. We examine the key assumptions associated with the mark-recapture
method, particularly how concepts within the ecological application of the method
relate to a covert human population. Developing on from the key assumptions,
we review some articles that critically assess whether the assumptions are met.
We then go on to examine the use of Bayesian methods within mark-recapture
estimation of drug use and also describe the use of open-population models in
estimating drug-using populations.
The mark-recapture methodology provides a sample-based solution to the
problem of estimating the size of a population when a census is infeasible, likely
to be unreliable or, by the nature of the population, impossible to carry out.
The obstacles to counting which almost always arise in relation to animal pop-
ulations, also often appear when human populations are the target. Thus the
famous Petersen-Lincoln estimator was eventually reinvented in the modern de-
mographic literature in a 1949 paper which bears – like many other innovations –
the name of W.E. Deming (Sekar and Deming, 1949), although much earlier ap-
plications have been traced within Buckland, Goudie and Borchers (2000). Sekar
and Deming faced the problem of estimating the total number of births and deaths
in a district where vital registration was incomplete. Their solution was to use a
door-to-door survey to correct the registration data in the now familiar way for
a two-source mark-recapture analysis. Their work was thus the forerunner of the
enormous number of applications in epidemiology which correct for incomplete
ascertainment in lists with partial coverage (Hook and Regal, 1995; International
Working Group for Disease Monitoring and Forecasting, 1995a,b), as well as the
area of evaluating the actual coverage achieved by censuses of (human) popu-
lations by means of post-enumeration surveys (Fienberg, 1992). It includes the
idea of estimating within sub-populations, partly in order to check the essential
assumption of independence between each source, but also as a means of reducing
the potential impact of heterogeneity in “capture” probabilities. In this respect
it anticipates the applications that concern us in the present paper.
Our focus here is on one important practical application: estimating the sizes of
populations of drug users, often within the confines of a single city, by application
of the mark-recapture methodology. The same methods are applicable to other
“hard to reach” populations, usually with public health implications, such as sex
workers (McKeganey et al., 1992). These applications differ from correcting for
incomplete ascertainment in that it is unlikely that there exists any list that
has some pretension to approaching comprehensive coverage of a well-defined
population. They thus come closer in concept to the ecological applications in
which a number of samples are drawn from the population. In our context, these
“samples” will be sources of information such as lists of drug users who attended
treatment services or were arrested by the police within a certain interval of time.
The natures of these samples - and indeed of the population itself - raise many
issues which demand consideration.
1.2 The Influence of Richard Cormack
We are indebted to Richard Cormack for providing support and advice during
the early studies in Scotland, which directly followed the approach to applying
the method outlined in Cormack (1985, 1992, 1989). In particular, he generously
shared his suite of macros in GLIM4 (Francis, Green and Payne, 1992) to repli-
MARK-RECAPTURE ESTIMATES OF DRUG USE 3
cate the approach outlined in that paper. Another important paper that informed
the earlier applications in the drug use field was Fienberg (1972), along with the
more general information about log-linear models in Bishop, Fienberg and Hol-
land (1975). The support that Richard Cormack gave was perhaps a double-edged
sword as it enabled researchers to be able to quickly generate mark-recapture esti-
mates once a contingency table, denoting presence and absence from different data
sources, had been constructed and translated into the format used by GLIM4,
or also SPSS, which was the main statistical package used by non-specialists to
carry out mark-recapture analyses. The downside was that the mark-recapture
method was now being used by researchers who perhaps did not have sufficient
statistical background to either apply anything more than the most standard
application of the method, or more worryingly to understand or check whether
they were applying the method correctly in the first place. While the same can
perhaps be said about any statistical method that is used by non-statisticians,
this may be a more prominent issue with the specialist or niche application of
the mark-recapture method to estimate drug use prevalence.
The review of drug use applications of mark-recapture methods includes several
acknowledgements of Cormack’s important contributions to a variety of studies
at the time when this area of application was still under development.
2. PROBLEM DRUG USE
It is a basic tenet in statistical investigation that a clear and unequivocal
definition of the population of interest is vital. Therefore, any study that aims
to estimate the prevalence of problem drug use needs to provide a description of
the case definition employed for identifying problem drug use. Measures of drug
dependence, such as the International Classification of Diseases (ICD) codes or
the Diagnostic and Statistical Manual of Disorders (DSM) diagnostic criteria are
not commonly used in sources of data on drug use and therefore would be of little
use in this type of prevalence estimation exercise. Rather, the study considers
drug use measures that are readily available in data that can systematically
be collated across the country. As such, the case definition of the prevalence
estimates depends heavily on the case definitions used by the contributing sources.
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
promotes the use of mark-recapture to estimate “high risk drug use” defined
as “recurrent drug use that is causing actual harms (negative consequences) to
the person (including dependence, but also other health, psychological or social
problems) or is placing the person at a high probability/risk of suffering such
harms” (EMCDDA, 2013). It is obvious that this is not a watertight, operational
case definition as would be expected in an epidemiological study. In fact, “it can
be considered a theoretical or conceptual definition [which] implies appropriate
flexibility in reporting” and “the main point of these case definitions is to filter
out experimental and occasional users who have a lower risk of harms and are
not the core population for the assessment of treatment need”(EMCDDA, 2013).
The difficulty of defining the population carries over into the difficulty of knowing
from which population each sample has been drawn and whether, in fact, they
have all been drawn from the same population. In a typical application, the
sources (samples) could include lists of clients entering treatment for a drug
use problem and lists of people arrested for drug use offences. Do these draw
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on the same population? These are not issues that arise uniquely in relation to
using mark-recapture methods among drug users, but they are always present
in these applications. It could be said that, in our area of application, the usual
relationship between population and sample is turned on its head. We do not
have a well-defined population from which we plan the sampling. Rather we
have samples that happen to be available – usually only three or four – and the
population is implied by the nature of these samples. For example, in Greece,
estimates have been obtained annually since 2004 by exploiting the fact that the
national database of demands for treatment for a drug problem is collected in
three parts, not by design but as a consequence of different services’ concerns over
data protection. Selecting only the clients who declare that their main substance
of abuse is a drug such as heroin and treating the three parts as separate sources
enables mark-recapture estimation of the population of high-risk drug users in
Greece as in Richardson and Antaraki (2015). Consequently we are estimating
the size of a pool of self-reported opioid abusers who are liable to seek treatment.
3. A STANDARD APPROACH
Along with recommending a common case definition such as high risk drug use,
the EMCDDA also recommends a standard approach to using mark-recapture
methods to estimate drug-use prevalence, following that used in early studies
that benefited from Cormack’s advice.
A standard set of Poisson log-linear models are fitted to the overlap data
recording the frequencies of patterns of presence/absence in the various data
sources (see example in Table 1). Where there are three sources of data on
drug users (the typical minimum number of sources for a mark-recapture study),
these models are: the independence model (with no relationships or interactions
between data sources), then three different models that each contain just one
two-way interaction, three further models that have two such interactions and a
“saturated” model that has three two-way interactions. As there is one missing
cell (the hidden population we are seeking to estimate) it is not possible to esti-
mate the three-way interaction. Comparing the value of the deviance to the χ2
distribution could suggest the “best” model and information criteria such as the
AIC value are also useful in assessing different models and estimates. An example
using four sources is given in Section 4.1, whereas Table 1 gives an example of
Greek data from 2012 used in a three-source analysis. The model that includes
the S2.S3 interaction (in addition to all three main effects) is a good fit in each
age group. The confidence intervals in Table 1 were obtained using the profile
likelihood method (Cormack, 1992; Regal and Hook, 1984).
Although models that include covariates such as age group and gender are
available, the typical approach in many of the earlier studies to deal with hetero-
geneity was to carry out separate analyses on stratified overlap tables, not least
because separate estimates by age (and by gender) are requested by agencies or
organisations such as the EMCDDA. In other circumstances, separate estimates
are obtained naturally for different geographical areas. If these must be combined
into a total, a question arises of how to construct a confidence interval around
the point estimate. One solution is to use bootstrapping methods, such as those
used by Gemmell et al. (2004) when summing estimates for ten areas of Greater
Manchester.
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Table 1
23 contingency tables (overlap tables) constructed from Greek data on presence/absence of drug
users in three treatment sources. “?” denotes the unobserved “hidden” population. The total
population is the total observed plus the estimated hidden population obtained from the
best-fitting model (S1+S2+S3+S2.S3) in each age group.
Source Age Group (years)
S1 S2 S3 15–24 25–34 35–64
Yes Yes Yes 1 8 7
Yes Yes No 12 118 51
Yes No Yes 1 28 18
Yes No No 139 1149 1239
No Yes Yes 10 74 20
No Yes No 143 694 308
No No Yes 41 212 124
No No No ? ? ?
Total observed 347 2283 1767
Estimated total population 2273 9595 9136
95% confidence interval 1478–3893 8142–11060 7546–11288
A natural objection to the standard approach described above is that it takes
no account of model uncertainty. Model averaging can be applied, as in Hook
and Regal (1997) who suggest using weights proprotional to e−AIC/2. However,
constructing model-averaged confidence intervals is problematic in the frequentist
framework (Claeskens and Hjort, 2008). On the other hand, model averaging
emerges naturally from a Bayesian analysis of the data (discussed later), which
can be carried out very easily using the R program ‘conting’ (Overstall and King,
2014).
There is debate as to whether fitting the saturated model is appropriate as,
by default, it always fits the data exactly. Because its fit cannot be assessed, it
is perhaps a leap of faith as to whether relying on the saturated model gives a
reliable estimate. In many of the early three-sample studies it can be noted that
the saturated model gives a higher estimate of the hidden population than models
with fewer interaction terms and this issue also perhaps makes some people try
to avoid fitting the saturated model.
There are, of course, assumptions underlying the application of mark-recapture
methods to estimating the size of animal or human populations. For our example
it is assumed that the population of drug users does not change during the study.
Specifically, it is assumed that drug users do not begin to use drugs or stop using
drugs and that drug users do not move into or out of the area that is being studied
within that time period. Clearly, these assumptions can hold only approximately
at best. The shorter the period, the more likely they are to be to be valid, but
the data – especially the overlaps on which mark-recapture depends – may be
sparse. The standard period of one year may be a reasonable choice but should
be examined. Some published studies have included sources with shorter time
periods, often in order to increase the number of sources. For example, the same
source of information in each trimester of the year was counted as four mark-
recapture sources in Domingo-Salvany et al. (1995). The same device has also
been used over two-year study periods in order to obtain first estimates in places
where data sources are limited (Choi and Comiskey, 2011; Kraus et al., 2011).
It is also assumed that drug users who are in more than one data source are
correctly identified as such. In the drug use example, this assumption usually
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relates to how accurately overlap cases can be identified when comparing initials
and dates of birth, particularly from data sources where accuracy of recording
may be less than that seen in, for example, clinical settings.
Although we do not require sources to be statistically independent (except
of course in a two-source analysis, which is not under discussion here) because
their dependence is handled by interaction terms in the log-linear model, there
is the possibility that the services and agencies that provide the data operate in
relation to each other. Suppose that presence in one source precluded presence in
another. This might be so if one source was prison or if the sources were mutually
exclusive forms of treatment. Then clearly the overlap between the two should be
a structural zero in the table and a more complicated analysis is required (or more
simply, the two forms of treatment could be combined into one source). Another
possible relationship is presence in one source implying presence in another as,
for example, arrested drug users being sent automatically to a treatment service,
in which case the police source would simply be a subset of the treatment source.
It is also assumed that the contributing data sources should be representative. In
order to meet this assumption, data sources must have equal coverage of the area
they serve and also be representative of gender, age group, ethnic group, type and
severity of drug use etc. That is not to say that, for example, a treatment service
should have equal numbers of female and male clients, rather the probability
that a female drug user in the community appears in a treatment data source is
similar to that of a male drug user (or that drug users in a rural part of a county
are as likely to access treatment as drug users living in a town or city). This is
an issue of homogeneity or heterogeneity which is often handled by breaking the
data down by gender, age and other groupings.
4. REVIEW OF THE DRUG USE APPLICATIONS OF
MARK-RECAPTURE
In this section we review some of the earlier applications of the mark-recapture
method in estimating the prevalence of problem drug use. Our focus is on studies
carried out within the United Kingdom (beginning with Scotland where Richard
Cormack is based and is most influential) which largely followed the “standard
approach” described above. We consider the one-off studies carried out in Scot-
land which led to a series of regular national and local estimates being produced
every three years, and go on to describe how prevalence estimation in England
also developed from various local studies into a more systematic application of
the method (and related methods) on an annual basis. We first review some of
the European work in this area.
4.1 European Studies
At the European level, the motivation for many of the earlier drug preva-
lence estimation studies was to provide information for organisations such as
the then newly established EMCDDA of the European Union or the Pompidou
Group of the wider Council of Europe. The EMCDDA jointly with the Pompi-
dou Group published a scientific monograph which included four chapters cover-
ing the application of mark-recapture methods to problem drug use prevalence
estimates (Domingo-Salvany, 1997; Richardson, 1997; Bello and Cheˆne, 1997;
Frischer, 1997). Both of the present authors have been associated with the EM-
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CDDA since it was established in 1995, particularly through their national centres
responsible for providing information on the issues of drug use in their countries.
These National Focal Points structure much of their reporting to the EMCDDA
around five Key Indicators, one of which is the size of the population of prob-
lem drug users or High-risk Drug Users. Mark-recapture is one of the methods
promoted in the guidelines for estimation (EMCDDA, 1999). Thus many EU
countries, plus Norway and Turkey, are regularly producing estimates using this
methodology.
Important early applications in Europe include studies in Barcelona, Spain
(Domingo-Salvany et al., 1995, 1998) and in Dublin, Ireland, where an estimate
initially attracted mixed responses (Comiskey, 2001; Comiskey and Barry, 2001)
but later seemed to be accepted (Kelly, Carvalho and Teljuer, 2003).
4.2 United Kingdom studies
In the 1980s the threat to public health of the spread of HIV/AIDS became
apparent. While initial attention focused on men who have sex with men and peo-
ple who inject drugs, it was recognised that HIV could spread via heterosexual
sex and could impact on groups other than the specific sub-groups it had initially
been seen in. In 1985, when a test for HIV became available, blood samples from
patients attending an accident and emergency department who were known to
be injecting were tested and over 60% were found to be positive (Robertson and
Richardson, 2007). This highlighted a public health threat, but without informa-
tion on the number of drug injectors in Edinburgh, little was known about the
total number of people infected with the virus.
As part of the team working within the Glasgow site of a World Health Orga-
nization multi-city study on HIV and drug injecting (Des Jarlais, 1994), Martin
Frisher became one of the first researchers in Europe to use the mark-recapture
method in a drug-using population, specifically to estimate the number of drug
injectors in Glasgow (Frischer et al., 1991; Frischer, 1992a; Frischer et al., 1993).
Although the title of one of the papers suggested that mark-recapture was a
new method in this context, which perhaps overlooked Hartnoll et al. (1985) and
Doscher and Woodward (1983), it does expand on the epidemiological grounding
of the method. That study can now be considered as ground-breaking, particu-
larly because it was the first to use four data sources and it demonstrated that a
successful study could use existing administrative data sources or data that were
being collected for other purposes (such as estimating HIV prevalence) and, unlike
Hartnoll previously, did not require a lot of additional data collection. It should be
noted that Frischer et al. (1993) includes Richard Cormack as an author, as does
a later paper by another group that provided estimates for Edinburgh (Davies,
Cormack and Richardson, 1999).
While pioneering the application of mark-recapture methods to estimating the
prevalence of problem drug use, Frisher was also required to defend the method
(Frischer and Leyland, 1992) and respond to criticism (Frischer, 1992b), such as
that in the commentary piece by Armstrong and Hayes (1992).
Later on in Scotland, a study set out to build upon the work of Frisher by
applying the method in Dundee (Hay and McKeganey, 1996; Hay, 1997). Richard
Cormack, although not credited as an author of the paper, provided support and
advice to the project team, particularly by allowing free access to his GLIM4
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macros (Cormack, 1985). The case definition of opiate and/or benzodiazepine
use was applied in an attempt to recognise the “hard drug use” situation in
that city at a time when a “heroin drought” had led to people using (including
by injection) benzodiazepines. Although that case definition was employed for a
specific situation, it has stuck for all subsequent drug use prevalence estimation
studies in Scotland, leading sometimes to difficulty in making comparisons to
opiate use estimates elsewhere in the UK or Europe. A similar study was carried
out in urban and rural areas of the north east of Scotland (Hay, 2000).
These local studies developed into a series of national prevalence estimation
exercises on a three-yearly basis that used a common methodological approach
stretching from 2000 to 2012 where trends can be examined (Hay and Gannon,
2006; Hay et al., 2009; Information Services Division, 2014).
An important point in the historical development of mark-recapture estimation
of the size of drug-using populations in the United Kingdom was Hartnoll et
al. (1987), who collated information on drug users in an area of London. That
study could be seen as arising from a local initiative which tried to quantitatively
assess drug use in a particular area, including applying prevalence estimation
methods such as multiplier methods or the two-sample mark-recapture method.
While aware of the benefits of using more than two sources of data within a mark-
recapture method, the published analyses in Hartnoll et al. (1985) were restricted
to the two-sample mark-recapture method. Hartnoll’s work could, in part, be seen
as responding to the increasing public health concerns about drug use when levels
of heroin use in some areas such as London were rising after staying relatively
stable since the introduction of the Misuse of Drugs Act in 1971.
Other local estimates in the United Kingdom produced in the 1990s include
Squires et al. (1995) who produced an estimate for Liverpool, Beynon et al. (2001)
who compared and contrasted estimates across the North West of England (an
area that experienced relatively high levels of opiate use in the early 1980s) and
Brugha et al. (1998) who applied the method in a more rural area. Elsewhere in
the United Kingdom, studies estimated the prevalence of drug use in Northern
Ireland (McElrath, 2002; Hay et al., 2006) and in Wales (Bloor, Wood and Palmer,
2000).
In 2002 the UK Government commissioned three methodological pilot studies
in England to estimate drug-use prevalence. One used mark-recapture methods
in Greater Manchester, updating previous estimates of the prevalence of opiate
use (Beynon et al., 2001). Another used mark-recapture methods to estimate the
prevalence of opiate use in Liverpool, Brighton and parts of Inner London (Hick-
man et al., 1992) and a third project used the multivariate indicator method
(MIM) to estimate the number of opiate users in England (Frisher, Heatlie and
Hickman, 2007). MIM, which was considered by the EMCDDA to be appropri-
ate for estimating the prevalence of opiate use at the national level (Kraus et
al., 2003), is essentially a multiple linear regression model which places available
prevalence estimates (derived using the mark-recapture method) in a regression
model with available “indicator” data such as numbers of opiate users in treat-
ment or other indicators that are thought to be correlated with opiate use.
Following on from these pilot studies, the UK Home Office commissioned a
series of annual estimates of the prevalence of opiate use in England, along with
estimates of the number of people who use crack cocaine or the number of people
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who use either opiates or crack (Hay et al., 2009, 2010, 2011). The intention was to
provide mark-recapture estimates for each of the 149 local areas of England, which
is the level at which the planning and provision of drug treatment services and
other responses to drug use is decided, and at which information on prevalence
is particularly needed. While the decision to stratify the analyses at the local
area level was more about providing local estimates, it also helped to address the
heterogeneity that would be present at the regional or national level. Where the
mark-recapture method failed to provide what was subjectively considered to be
a valid estimate then MIM would be used to fill in the gaps.
The four data sources on problem drug use which could be used within these
mark-recapture analyses were treatment, police, prison and probation data and
these were all held centrally at the national level. The available data allowed
analyses at the local (n=149), regional (n=9) and national level. Age group and
gender could be used to stratify the data. As a key objective of the study was
to obtain comparable estimates in order to assess differences between areas and
changes over time a standard analysis plan was developed (Hay et al., 2010).
Essentially it restricts model fitting to a set of 22 simple models and seeks the
“best estimate” for a particular area by considering different combinations of
estimates stratified by age group and/or gender. The 22 simple models were the
independence model, six models with only one two-way interaction and the fifteen
models that include a pair of two-way interactions. Various methods were used
to explore whether the model fitted to the unstratified data was a good fit (in
particular by considering the AIC value). If none of those approaches provided
what was thought to be a valid estimate then MIM was used instead. Estimates
for specific age groups were obtained in a similar manner to that outlined in Hay
et al. (2009), which involved deriving an estimate for the proportion in each age
group from the best available information (typically mark-recapture estimates
that employed model-averaging over the simplest 22 models) and applying those
proportions to the “best” available estimate which could be a MIM estimate.
Confidence intervals for the regional and national estimates were obtained using
the approach outlined in Gemmell et al. (2004). This led to extreme asymmetry
in the confidence intervals for the age group estimates, most likely due to the
large number of confidence intervals that had been approximated by simulated
distributions. Table 2 gives an example of the data for an area of London.
Across the years of the English studies, the national estimates stratified by age
group suggest that the number of opiate users aged 15 to 24 decreased over time,
as did those in the 25 to 34 age range (Table 3). Analyses based on simulation
methods confirmed these significant differences. Interestingly the estimates in the
older age group increased over time. As the increase each year is similar to the
number of opiate users who would turn 35 and therefore move into the older age
range, the increases could perhaps be explained as being due to an ageing cohort.
A consistent finding across the successive years of the English studies is that
estimates at lower area levels have relatively wide confidence intervals which do
not allow significant changes to be identified across time, but adding estimates to
get regional or national estimates reveals more consistent trend information. The
level of geographical stratification is important. Stratifying to the lowest level
possible maximizes the information provided, although the resulting compara-
tively large confidence intervals may render over-stratified estimates worthless.
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Table 2
A typical overlap pattern found in an area of London, Year 1 to Year 8; by age group in Year 8
Source Year 1 Year 2 Year 3 Year 5 Year 6 Year 7 Year 8
S1 S2 S3 S4 15-64 15-64 15-64 15-64 15-64 15-64 15-24 25-34 35-64
Yes Yes Yes Yes 0 0 0 2 2 1 0 0 0
Yes Yes Yes No 0 0 1 1 0 0 0 0 0
Yes Yes No Yes 1 3 3 7 5 2 1 0 0
Yes Yes No No 2 5 4 19 8 2 0 0 0
Yes No Yes Yes 0 0 0 0 0 1 0 0 0
Yes No Yes No 0 1 1 0 2 0 0 0 0
Yes No No Yes 0 2 1 1 1 0 0 0 0
Yes No No No 4 10 11 12 17 22 8 10 1
No Yes Yes Yes 3 3 16 15 10 15 1 4 3
No Yes Yes No 9 6 11 30 22 19 0 7 9
No Yes No Yes 10 14 29 26 33 37 2 10 21
No Yes No No 280 342 339 342 348 361 25 128 208
No No Yes Yes 3 0 1 5 4 3 0 0 4
No No Yes No 11 13 16 28 31 25 5 12 6
No No No Yes 4 17 14 27 32 32 1 9 6
No No No No ? ? ? ? ? ? ? ? ?
Table 3
Table summarising prevalence estimates by age group in England
Year Age 15–24 Age 25–34 Age 35–64
Estimate 95% CI Estimate 95% CI Estimate. 95% CI
1 59583 n.a. 124004 n.a. 97740 n.a.
2 51099 (50311 – 54569) 129128 (125614 – 134005) 106264 (104113 – 111433)
3 44398 (43296 – 47493) 118385 (115969 – 123126) 110340 (107905 – 114727)
5 36546 (35193 – 39879) 109509 (106991 – 111604) 116374 (113981 – 118513)
6 35740 (34204 – 37449) 105770 (103035 – 108132) 122563 (119442 – 125031)
7 30278 (28819 – 31980) 100887 (98739 – 103213) 130628 (127847 – 133506)
8 24942 (23475 – 26488) 95950 (93352 – 97923) 135271 (131740 – 137843)
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Also, when summing local estimates to get regional or national estimates, it
may be beneficial to keep the number of stratified estimates low in order that
the larger area estimates do not have over-large confidence intervals. Questions
should, however, be asked about the comparability of estimates when some of
the mark-recapture analyses are for relatively large geographical areas covering
an urban and rural mix and some for relatively small urban areas.
There may have been merit in stratifying large areas into geographical sub-
areas to see if geographical heterogeneity was present. There did appear to be an
issue in the analyses that the simplest 22 models (as described above) were less
likely to provide an adequate fit in the larger geographical areas and consistently
throughout the repeated years of the study there were areas where all of the
deviance values for the simplest 22 models were far in excess of that found in
other areas, perhaps indicating that there could be some breach of the mark-
recapture assumptions. There is also the issue that, just because it is possible
to get models to fit the data, it does not necessarily mean that the assumptions
hold and that the estimates are reliable.
5. METHODOLOGICAL ADVANCES
In this section we examine how the “standard approach” has been further
developed in two respects to try to address some of the particular methodological
issues in using mark-recapture to estimate drug use prevalence.
5.1 Bayesian approach
Naturally, the Bayesian approach to log-linear modelling of mark-recapture
data on drug users has been considered. The best examples can be found in a se-
ries of papers concerning the estimation of the number of people who inject drugs
in Scotland in different years (King et al., 2005, 2009, 2013) and subsequently in
England (King et al., 2014). In marked contrast to the innumerable applications
of Bayesian methodology throughout the statistical literature in which only un-
informative prior distributions are employed, these papers set out in detail their
priors based on expert opinion and results obtained elsewhere.
The advantages of the Bayesian approach include the natural way of averag-
ing across models by weighting according to the posterior probabilities of models
that have been examined in the Markov chain Monte Carlo procedure. Similarly,
inclusion of a specific interaction can be judged on the basis of a probability
rather than as the yes-no decision taken in the usual frequentist model selection.
Of course, all this takes place within a specific set of models. The Scottish data
form a 27 contingency table constructed from four sources and three two-level
covariates (age, gender, region) with one missing cell for each combination of the
covariate values. In order to keep the number of models to manageable propor-
tions, non-zero prior probabilities were assigned only to the two-way interactions.
Consequently, models containing three-way and higher order interactions were ex-
cluded. This might be reasonable as far as the sources are concerned, but possibly
requires examination for interactions that also include covariates.
An interesting feature of the posterior probability densities of total population
size in some analyses was the appearance of bimodality. This can be seen most
clearly in the Scottish data for 2003 presented in Figure 1 of King et al. (2009)
with a low peak at about 22000 and a higher one around 30000. The greater
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posterior probability attached to the model that produced the latter estimate
resulted in a final estimate of 27357. The difference between the two peaks was
traced chiefly to whether or not the interaction between sources S3 and S4 was
included. As the coefficient of the corresponding term in the log-linear model had
positive posterior mean, its exclusion would tend to reduce the estimated popu-
lation sizes. This interaction had a lower posterior probability (0.84) for inclusion
than the other terms that appeared to be required, indicating some support for
its exclusion and hence the presence of the lower peak. The fuller model con-
taining S3.S4 might not have been identifed within the conventional frequentist
approach. There are too many possible models to search through all in order to
find the “best” (for example, by smallest value of AIC). However, starting as
did King et al. (2009) by excluding three-way and higher order interactions from
consideration, the usual process of eliminating and reinserting terms as neces-
sary does lead in the end to their model that contains 12 two-way interactions
including S3.S4. However, if one were to start from the model that includes all 3-
way interactions, then the need for S1.Age.Gender and S4.Age.Gender would be
indicated. Neither seems a priori unreasonable. Eliminating superfluous two-way
interactions results in a model with good fit (deviance 113.1 on 96 d.f., p = 0.11;
AIC 583.4 compared to 582.4 from the model with the 12 2-way interactions).
Lacking the S3.S4 interaction, however, it gives a relatively low estimate of pop-
ulation size. This example indicates the difficulty of selecting a final model for a
large table. However, one factor that may have played a role could be that the
table is relatively sparse, with 24 sampling zeros in its 120 cells; only 46 of the
7201 observations represent people who were observed in three sources and only
one person appeared in all four.
5.2 Open populations
The typical mark-recapture analysis for estimating the size of a population of
drug users is based on a small number of contemporaneous samples (often only
three), using anonymised identification codes in order to match people between
samples and estimating the size of the closed population over a short period
of time. This automatically excludes drawing upon the vast literature on mark-
recapture analysis in other fields, which is largely based on successive sampling,
possibly over a long period, a structure that enables – and in fact demands
– the consideration of open populations. However, if the mark-recapture data
on drug users are collected each year, this raises the possibility of studying an
open population by matching across years to construct a capture history as in
an ecological application. This will not always be feasible for practical reasons.
Even with routine administrative sources, coding the identifiers is sometimes
only carried out upon special request for the particular purpose of performing
one-off mark-recapture estimation. In other cases, because of anxiety over data
confidentiality, the codes are used solely for matching within the year and then
deleted, so that they are not available for further use. However, if an agency
holds its own data and constructs the codes as a matter of course, an open
population analysis over years could be carried out in principle, based on the
seminal work of Jolly (1965) and Seber (1965). Among other things, this could
show the incidence of starting drug use, complementing the prevalence indicated
by the existing annual estimates.
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There have been some studies that include an open-population mark-recapture
analysis. In comparing different approaches to estimating the size of a drug-using
population in Sydney, Australia, Kimber et al. (2008) use a parameterization of
the Jolly-Seber model due to Schwarz and Arnason (1996). More recently, using
the same parameterization Van Dam-Bates, Fyfe and Cowen (2015) published
an analysis of just three years’ data for the city of Victoria, Canada. Other
proposals for using the Jolly-Seber model date back to a special journal edition
of the Journal of Drug Issues where Hser (1993) and Brecht and Wickens (1993)
consider the same application of the method to data for Los Angeles County
(with the latter also using simulated data to compare methods). Both articles
concluded that the Jolly-Seber model underestimated the true population size.
A more extensive analysis is currently in progress of 13 years of Greek data,
using records from only one of the three treatment sources mentioned above as
being employed in the annual estimation procedure (codes from the other two
sources are not retained because of confidentiality concerns). Although the first
results appear to need considerable refinement, especially because of poor fit to
individuals who appear repeatedly, they show a high degree of consistency with
the annual three-source estimates, which may not be surprising given the use of
the same data in both analyses. Unfortunately, the annual incidence (“birth” in
the usual terminology of open population analysis), is rather poorly estimated
with typical values around 3000-4000 and standard errors of about 700.
One possibly important advantage of the open population analysis is that it
only requires a single source; consequently, it can be applied when the minimum
requirement of three sources for the closed population mark-recapture analysis is
not met. Of course, as is well known, population size for the latest year cannot be
estimated except by imposing equal capture probabilities across years, which may
be undesirable. As an aside, we mention here that another well-known method
for estimating annual population sizes from repeated captures in a single source
is sometimes applied to drug users. This is the analysis based on the truncated
Poisson distribution for the number of captures using, for example, Zelterman’s
estimator, see Bo¨hning and Van der Heijden (2009). This method has been used
in a number of settings, such as estimating the number of drug users in Bangkok,
Thailand (Bo¨hning et al., 2004) and estimating the number of injectors in Ab-
erdeen using data from a needle exchange (Hay and Smit, 2003).
6. DISCUSSION
We have demonstrated that the mark-recapture method can be used to esti-
mate the prevalence of problem drug use both at the local level and, usually in
conjunction with other statistical methods, at the national level. Thus Scotland
and England have acquired series of prevalence estimates following the same ap-
proach (originally based on the advice and support of Richard Cormack) applied
systematically across time. These studies have identified that the prevalence of
problem drug use in Scotland has remained relatively constant, whereas in Eng-
land it appears to be decreasing, particularly amongst younger people. Across
Europe various local estimates, again obtained using mark-recapture, are inform-
ing the work of the EMCDDA.
It has, however, become increasingly difficult to carry out a mark-recapture
study, not because of the methods (or even changes in the nature of the data),
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but due to increased concerns about sharing the type of personal data (such as
initials and dates of birth) required to identify overlaps. Even in countries where
all citizens have unique identification codes – for example Denmark where mark-
recapture has been used to estimate the prevalence of hepatitis (Christensen et
al., 2012; Hansen et al., 2014) – issues relating to data protection legislation and
client or patient confidentiality are becoming more and more prominent. While
it is possible to construct unique numeric codes to anonymise or “pseudonymise”
personal data, since these are based on personal data the data protection con-
cerns still remain (along with all the attendant data security issues such as safe
storage and transfer). A perfect way of anonymising the personal data for match-
ing should not detract from the ability to carry out a mark-recapture study, but
often this can introduce an added layer of complexity into the analysis or prevent
identification of problems with the data.
Data providers such as the police or treatment services usually consider the
data they are asked to provide as personal and confidential and often seek to
restrict use to the purpose for which it was requested. While it can be argued
that the overlap data are sufficiently removed from personal data (particularly
when cell values are large enough to prevent deductive disclosure), data providers
sometimes place restrictions on the dissemination and publication of such data.
The peer-review process of Hay et al. (2009) requested that the original overlap
patterns be supplied in an appendix, however permission to do this was not forth-
coming from the contributors of data and even the published information about
which models were fitted to the overlap data was not for named areas. Although
for a statistician it would be good practice to share source data, it has not always
been possible with the data collected during the various United Kingdom mark-
recapture studies, the notable exception being the studies that applied Bayesian
mark-recapture methods to the same data in England and Scotland; this involved
the original study team preparing overlap patterns in the required format (such
as aggregating up to regional level).
There has been criticism of the “standard approach” used within the United
Kingdom studies. In part this criticism is justified as the behaviours of human
populations and their involvement with criminal justice services and drug treat-
ment agencies are complex and it would be over-optimistic to believe that the
mark-recapture assumptions are fully valid. Since the increase in the use of the
method to estimate the size of drug-using populations in the 1980s and 1990s
there has been criticism such as Waters (1994) who felt more validation of the
method was required in response to LaPorte (1994) who suggested that mark-
recapture could bring about a “paradigm shift in how counting is done in all the
disciplines that assess human populations”.
The validity of the English estimates was also questioned by Frisher and
Forsyth (2009) who pointed out that an increase in prevalence between 2001 and
2004 was not matched by other available data such as the number of drug-related
deaths or the number of hospital admissions due to drug abuse.
More recently Jones et al. (2014) suggest that standard mark-recapture meth-
ods may be fallible when used to estimate the size of covert human populations,
particularly in the presence of referrals between data sources such as when the
police or a prison refer people into drug treatment. They suggest that this issue is
not quite the same as the main assumptions that are routinely considered when
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using mark-recapture. Their approach to trying to demonstrate this proposed
fallibility is based on highlighting differences between the results of their anal-
yses and the estimates that had been previously published using the same data
in Hay et al. (2011), which carried out the analyses at the local area level and
often stratified by age group or gender (as well as area of residence) as it was
thought unlikely that all drug users across England demonstrated equal “capture
probability”. Jones et al. (2014) did not consider geographical, age or gender
heterogeneity as they carry out their analyses only with data aggregated up to
the national level. Their simulated datasets are similarly only analysed at the
national level.
The use of a second method in some areas was not noted in the comparisons.
This is an important omission as MIM was used in the English analyses when
the mark-recapture method failed to provide a valid estimate when fitting the
22 simplest models. This could be because these models do not fit the data due
to remaining heterogeneity, dependencies between data sources or indeed the
referral issue they are proposing. It could also be due to data quality issues at
the local level, something that is not unknown when analysing data on covert
populations such as drug users. It is often seen that fitting more complicated
models increases the estimated population size, which could be a true reflection
of prevalence or an inappropriate attempt at dealing with unreliable data. Fitting
over-complicated models at the national level could therefore be one of many
reasons why the comparisons they make may not be valid. The same can be said
about the Bayesian analyses that always fit mark-recapture models, albeit at the
regional level, even when it has been difficult to fit models at the lower area level.
Finally the criticism of the “standard approach” is based on various three-
sample analyses, some of which involve fitting less commonly used non-hierarchical
log-linear models. They cite Richard Cormack’s description of fitting a three-way
interaction when only three sources are available, as a ‘leap of faith’ (Cormack,
1999). In the three-source scenario it usually is indeed a leap of faith, which is
one of the reasons why the English series of annual analyses avoided using only
three sources. However when using four sources, fitting a four-way interaction is
less of a leap of faith when the available data suggest that the leap from two-way
to three-way interactions is not required.
We have presented in some detail the use of mark-recapture methodology to
estimate the sizes of populations of drug users. This is possibly the most common
application of the method in the social sciences. Much of this work is carried out
at a relatively unsophisticated level by the standards of modern statistical mod-
elling, a situation which could and should be improved. However, it is our impres-
sion that there is a general feeling that the quality of the data that are available
in these applications is not adequate to support more than basic analyses. Mark-
recapture samples often comprise what already exists or can be extracted from
overworked and understaffed services, rather than what would be employed in an
ideal world. Practical problems often dominate. Some of these may be the same
in nature, although not necessarily in degree, as in other areas of application. For
example, imperfect matching across samples may occur in other epidemiological
analyses or in ecological studies, but may be more prominent when the use of
anonymised identification codes is a necessity and some of the matching infor-
mation is provided by people who may have low trust in services and could be
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under the influence of drugs.
The major difficulty of case definition has been mentioned earlier, as well as
the difficulty of ensuring that the sources employ the same definition and thus
can be regarded as drawn from the same population. Often, this will not be
true. Police records and interviews with trained psychologists in a treatment
service are unlikely to agree on the details of an individual’s status as a drug user
(substances used, injecting behaviour). The hope is that they agree sufficiently,
although assessing the validity of this pious hope is difficult and perhaps rarely
undertaken. It is worth mentioning, though, some methodological innovations
that address the issue of incomplete agreement between sources. Van der Heijden,
Zwane and Hessen (2009) treat the problem of lists that refer to non-identical
(though overlapping) regions, time periods and age or other groups by applying
the EM algorithm to the analysis of the incomplete tables formed from these lists.
The same authors, and also Zwane and Van der Heijden (2007) and Zwane and
Van der Heijden (2008) consider the similar issue raised by non-identical sets of
covariates associated with each source. Overstall et al. (2014), continuing their
analyses of Scottish data, presented a method of allowing for a broader definition
in one of the four sources than in the other three. Specifically, the hepatitis
C virus diagnosis database did not distinguish past from current drug injectors
which made its use in the estimation of the number of people who currently inject
drugs problematic. This broader definition implies that the contingency table cell
counts referring to people who were present only in that database and not the
others are left-censored. An extension of previous models to include this feature
allowed this source’s inclusion in the modelling.
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